PPT-Imiglucerase Drugbank ID

DB00053 Protein chemical formula C 2532 H 3854 N 672 O 711 S 16 Protein average weight 555974000 Halflife 36104 min Description Human Beta glucocerebrosidase. Figure1:Schemainterlinkingforthreedatasetsi.e.DrugBank,Sider,Diseasome. Figure2:Resourcesfromthreedierentdatasetsarefusedattheinstancelevelinordertoexploitin-formationwhicharespreadacrossdiversedatas Figure1:Schemainterlinkingforthreedatasetsi.e.DrugBank,Sider,Diseasome. Figure2:Resourcesfromthreedierentdatasetsarefusedattheinstancelevelinordertoexploitin-formationwhicharespreadacrossdiversedatas Colin Batchelor. ,. Ken Karapetyan, Valery Tkachenko, Antony Williams. 6th Joint Sheffield Conference on . Chemoinformatics. 2013-07-24. Overview. Open PHACTS and chemical validation and standardization. : . DB00031 . Protein chemical . formula . : C. 2561. H. 3919. N. 747. O. 781. S. 40. Protein . average . weight : . 58951.2000. Half life : . 1.9 hours (mammalian reticulocytes, in . vitro. ). Description. DB00005 . Half life : . 102 /- 30 hrs . Description. . :. Enbrel. (. etanercept. ) is a . dimeric. fusion protein consisting of the extracellular . ligand. -binding portion of the human 75 . kilodalton. DB09052 . Description. . :. Blinatumomab. is a . BiTE. -class (bi-specific T-cell engagers) constructed monoclonal antibody indicated for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). . Toxins . Biol. 445. Introduction. I had always heard that dogs were “allergic” to chocolate. I wanted to find . . 1. if this was true, and. . 2. what substance in chocolate could be responsible for this. . DB00002 . Protein Chemical formula : . C. 6484. H. 10042. N. 1732. O. 2023. S. 36. . Protein Average . wt. . : . 145781.6 . Half life : . Approximately : . 114 hrs . Description. :. . Erbitux. is a targeted therapy.  It is classified as a "monoclonal antibody" and "signal transduction inhibitor" by binding to epidermal growth factor receptors (EGFR).. ID . : . DB00019 . Protein chemical . formula : . C. 845. H. 1343. N. 223. O. 243. S. 9. Protein . average . weight : . 18802.8000. Half life : . 15-80 hrs . Description. . :. . PEGylated. (at N terminus) form of human G-CSF (Granulocyte colony stimulating factor), 175 residues, produced from E. coli via bacterial fermentation. . DB00059. . Protein chemical . formula : . C. 1377. H. 2208. N. 382. O. 442. S. 17. Protein . average . weight : . 31731.9000. Description. . : . Pegylated. . L-asparagine . amidohydrolase. from E. coli. . ID : . DB09560 . Indication. . :. Patients with Cancer Receiving . Myelosuppressive. Chemotherapy: to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with . Immunosuppressive Agents . RILONACEPT . . DESCRIPTION. INDICATION. Rilonacept. is a . dimeric. fusion protein consisting of portions of IL-1R and the IL-1R accessory
 protein linked to the . ID . : . DB00008 . Protein average . weight : . 60000.0000. . Half life : . Terminal half life is 80 hours (range 50 to 140 hours). . . Description. :. . Human interferon 2a, is a covalent conjugate of recombinant alfa-2a interferon with a single branched . Shaare. . Zedek. Medical Center. Hebrew University and Hadassah Medical School. Jerusalem, Israel. Toronto, MAB, June 21. st. 2018. SWITCH OVER DATA. Clinical trials, EAP and “real life”. Disclosures .